Analyst Consensus ?
ConsensusBuy27 ratings
Bullish1763.0%
Neutral933.3%
Bearish13.7%
Citigroup Inc. · C · FY2024 Q3 · Calendar Q4 2024
Citi: Fee growth and transformation progress offset execution risks
Citi's Q3 results support a constructive but conditional thesis: fee growth, wealth momentum, and transformation progress provide operating support, while expense execution, regulatory work, rates, and credit normalization could limit the pace of improvement.
Reported Before market openNYSEFinancial Services
$202.33B market cap
100quality score
Earnings scorecard
Reported versus consensus
Reported EPS
$1.51
Consensus $1.31
EPS surprise
+15.3%
Reported versus consensus
Reported revenue
$20.32B
Consensus $19.86B
Revenue surprise
+2.3%
Reported versus consensus
Market reaction
prior-close to event-session close
Stock move
-5.1%
Event window
SPY move
-0.8%
Same window
Abnormal move
-4.3%
Stock minus SPY
Volume
3.0×
Versus trailing sessions
Subsequent drift
+10.2%
Up to 20 sessions
CSPY benchmark
Ask FN2 about C FY2024 Q3
Transcript, numbers and history already loaded
Why did C fall 5.1% after beating EPS estimates in FY2024 Q3?What changed in C's guidance and outlook in FY2024 Q3?Give me the bull and bear case for C after FY2024 Q3 earnings.
Free account. Your question opens in FN2 with this report's transcript and numbers attached.
Transcript intelligence
What changed
Compared with the prior quarter, Citi reported continued fee-led growth and positive operating leverage, with wealth investment assets up 24% year over year and RoTCE improving to 8.5%. Management also highlighted further regulatory-remediation progress, including closure of a third AML/BSA consent order, while expense guidance stayed at the high end of its range.
Guidance delta
Maintained; full-year expense guidance remains at the high end of the $51-$53 billion range.
Key takeaways
- Q3 revenue increased 3%, with double-digit fee growth and positive operating leverage across businesses.
- Wealth client investment assets increased 24% year over year, while RoTCE improved to 8.5%.
- Transformation and regulatory remediation progressed, but expense execution and credit normalization remain key watch items.
Management priorities
- Continue technology simplification, transformation, and cost reduction.
- Expand fee businesses including Services, Wealth, and Markets.
- Complete the Banamex separation and prepare for a planned IPO by the end of 2025.
- Broaden private-credit partnerships and cross-border payment capabilities.
Follow C with an agent that reads every filing, transcript, and price print. Free to start.
Try FN2 freeEarnings History
Estimate
Beat
Miss
Match
Analyst 52W Price Targets
$120.62Current
$50Low
$114.05Average
$165High
Latest persisted target per named analyst; persisted current price from FN2's market snapshot as of Oct 25, 2026. Not an FN2 forecast.
Firm-level rating actions
FMP grade actions identify the grading firm, not a named analyst.
| Firm | Rating | Prior rating | Action | Date |
|---|---|---|---|---|
| TD Cowen | Buy | Buy | Maintain | Oct 14, 2026 |
| RBC Capital | Outperform | Outperform | Maintain | Oct 14, 2026 |
| Evercore ISI Group | In Line | In Line | Maintain | Oct 14, 2026 |
| UBS | Neutral | Neutral | Maintain | Oct 5, 2026 |
| JP Morgan | Overweight | Overweight | Maintain | Oct 2, 2026 |
| HSBC | Buy | Buy | Maintain | Sep 28, 2026 |
| Truist Securities | Buy | Buy | Maintain | Jul 15, 2026 |
| B of A Securities | Buy | Buy | Maintain | Jul 7, 2026 |
| Oppenheimer | Perform | Outperform | Downgrade | Jun 30, 2026 |
| Morgan Stanley | Overweight | Overweight | Maintain | Jun 29, 2026 |
| Wells Fargo | Overweight | Overweight | Maintain | Jun 18, 2026 |
| Keefe, Bruyette & Woods | Outperform | Outperform | Maintain | May 8, 2026 |
| Piper Sandler | Overweight | Overweight | Maintain | Apr 15, 2026 |
| Goldman Sachs | Buy | Buy | Maintain | Apr 15, 2026 |
| Barclays | Overweight | Overweight | Maintain | Apr 15, 2026 |
| Freedom Broker | Buy | Buy | Maintain | Jan 29, 2026 |
| Argus Research | Buy | Buy | Maintain | Mar 18, 2025 |
| BMO Capital | Market Perform | Market Perform | Maintain | Jul 15, 2024 |
| Jefferies | Hold | Hold | Maintain | Apr 8, 2024 |
| Wolfe Research | Outperform | Peer Perform | Upgrade | Jan 3, 2024 |
| Odeon Capital | Buy | Hold | Upgrade | Jul 18, 2023 |
| Credit Suisse | Neutral | Neutral | Maintain | Jul 17, 2023 |
| Deutsche Bank | Hold | Hold | Maintain | Sep 12, 2022 |
| Atlantic Equities | Neutral | Overweight | Downgrade | Mar 3, 2022 |
| Sterne Agee | Buy | Buy | Maintain | May 22, 2012 |
| JMP Securities | Underperform | Market Perform | Downgrade | May 21, 2012 |
| Meredith Whitney Advisory Group | Hold | Underperform | Upgrade | Apr 18, 2012 |
Named analyst price targets
Upside is calculated against the persisted current price $120.62. FMP does not supply a rating on these named-analyst rows.
| Firm | Analyst | 52W target | Price when posted | Upside | Date |
|---|---|---|---|---|---|
| UBS | Analyst unavailable | $148 | $122.74 | +22.7% | Oct 14, 2026 |
| RBC Capital | Gerard Cassidy | $135 | $122.13 | +11.9% | Oct 14, 2026 |
| Evercore ISI | Analyst unavailable | $135 | $122.76 | +11.9% | Oct 14, 2026 |
| Loop Capital Markets | Analyst unavailable | $155 | $124.53 | +28.5% | Oct 13, 2026 |
| Evercore ISI | Glenn Schorr | $140 | $129.53 | +16.1% | Oct 1, 2026 |
| HSBC | Analyst unavailable | $164 | $133.64 | +36.0% | Sep 28, 2026 |
| UBS | Analyst unavailable | $142 | $132.44 | +17.7% | Aug 3, 2026 |
| Truist Financial | Analyst unavailable | $154 | $133.74 | +27.7% | Jul 15, 2026 |
| Argus Research | Analyst unavailable | $150 | $133.7 | +24.4% | Jul 15, 2026 |
| Evercore ISI | Glenn Schorr | $143 | $142.62 | +18.6% | Jul 6, 2026 |
| Morgan Stanley | Manan Gosalia | $164 | $142.57 | +36.0% | Jun 29, 2026 |
| Truist Financial | Analyst unavailable | $158 | $142.41 | +31.0% | Jun 26, 2026 |
| Wells Fargo | Analyst unavailable | $165 | $143.85 | +36.8% | Jun 18, 2026 |
| Oppenheimer | Analyst unavailable | $145 | $130.16 | +20.2% | May 8, 2026 |
| Truist Financial | John McDonald | $147 | $129.49 | +21.9% | May 1, 2026 |
| Wells Fargo | Analyst unavailable | $162 | $128.53 | +34.3% | Apr 29, 2026 |
| Evercore ISI | Analyst unavailable | $139 | $130.79 | +15.2% | Apr 15, 2026 |
| RBC Capital | Gerard Cassidy | $139 | $129.65 | +15.2% | Apr 15, 2026 |
| Truist Financial | John McDonald | $139 | $129.65 | +15.2% | Apr 15, 2026 |
| Morgan Stanley | Manan Gosalia | $144 | $129.65 | +19.4% | Apr 15, 2026 |
| Piper Sandler | Analyst unavailable | $145 | $129.65 | +20.2% | Apr 15, 2026 |
| Goldman Sachs | Richard Ramsden | $151 | $129.65 | +25.2% | Apr 15, 2026 |
| Wells Fargo | Analyst unavailable | $160 | $129.65 | +32.6% | Apr 15, 2026 |
| Barclays | Jason Goldberg | $154 | $129.65 | +27.7% | Apr 15, 2026 |
| Truist Financial | Analyst unavailable | $133 | $112.41 | +10.3% | Mar 26, 2026 |
| Morgan Stanley | Manan Gosalia | $152 | $113.92 | +26.0% | Feb 17, 2026 |
| UBS | Erika Najarian | $132 | $116.96 | +9.4% | Jan 15, 2026 |
| Morgan Stanley | Betsy Graseck | $135 | $116.44 | +11.9% | Jan 15, 2026 |
| Oppenheimer | Chris Kotowski | $144 | $112.41 | +19.4% | Jan 15, 2026 |
| Piper Sandler | Analyst unavailable | $135 | $112.41 | +11.9% | Jan 15, 2026 |
| Wolfe Research | Analyst unavailable | $141 | $121.45 | +16.9% | Jan 7, 2026 |
| HSBC | Analyst unavailable | $87 | $121.02 | -27.9% | Jan 7, 2026 |
| Truist Financial | Analyst unavailable | $129 | $123.31 | +6.9% | Jan 6, 2026 |
| Goldman Sachs | Analyst unavailable | $127 | $123.31 | +5.3% | Jan 6, 2026 |
| Wells Fargo | Mike Mayo | $150 | $122.7 | +24.4% | Jan 5, 2026 |
| Barclays | Jason Goldberg | $146 | $118.69 | +21.0% | Jan 5, 2026 |
| Truist Financial | John McDonald | $123 | $113.62 | +2.0% | Dec 18, 2025 |
| Wolfe Research | Steven Chubak | $121 | $111.28 | +0.3% | Dec 17, 2025 |
| Piper Sandler | Analyst unavailable | $118 | $109.43 | -2.2% | Dec 10, 2025 |
| Piper Sandler | Analyst unavailable | $120 | $109.43 | -0.5% | Dec 10, 2025 |
| UBS | Erika Najarian | $108 | $99.63 | -10.5% | Nov 24, 2025 |
| Cowen & Co. | Analyst unavailable | $110 | $99.36 | -8.8% | Oct 15, 2025 |
| Morgan Stanley | Betsy Graseck | $134 | $101.62 | +11.1% | Oct 15, 2025 |
| Piper Sandler | Analyst unavailable | $110 | $99.84 | -8.8% | Oct 15, 2025 |
| Barclays | Analyst unavailable | $115 | $99.84 | -4.7% | Oct 15, 2025 |
| Goldman Sachs | Richard Ramsden | $118 | $99.84 | -2.2% | Oct 14, 2025 |
| Morgan Stanley | Analyst unavailable | $129 | $103.42 | +6.9% | Sep 29, 2025 |
| Wells Fargo | Mike Mayo | $125 | $99.54 | +3.6% | Sep 16, 2025 |
| Truist Financial | John McDonald | $105 | $93.82 | -12.9% | Sep 3, 2025 |
| Oppenheimer | Chris Kotowski | $123 | $89.03 | +2.0% | Jul 16, 2025 |
| Morgan Stanley | Betsy Graseck | $103 | $88.78 | -14.6% | Jul 7, 2025 |
| RBC Capital | Gerard Cassidy | $78 | $62.1 | -35.3% | Apr 16, 2025 |
| Truist Financial | Analyst unavailable | $84 | $58.13 | -30.4% | Apr 4, 2025 |
| Bank of America Securities | Ebrahim Poonawala | $78 | $62.64 | -35.3% | Oct 16, 2024 |
| Oppenheimer | Chris Kotowski | $91 | $62.64 | -24.6% | Oct 16, 2024 |
| Morgan Stanley | Betsy Graseck | $82 | $62.64 | -32.0% | Oct 16, 2024 |
| Evercore ISI | Glenn Schorr | $64 | $62.64 | -46.9% | Oct 16, 2024 |
| CFRA | Kenneth Leon | $73 | $62.64 | -39.5% | Oct 15, 2024 |
| Goldman Sachs | Richard Ramsden | $71 | $57.95 | -41.1% | Sep 10, 2024 |
| Piper Sandler | Scott Siefers | $73 | $61.06 | -39.5% | Sep 3, 2024 |
| Morgan Stanley | Betsy Graseck | $79 | $64.3 | -34.5% | Jul 30, 2024 |
| Goldman Sachs | Richard Ramsden | $72 | $65.5 | -40.3% | Jul 15, 2024 |
| Oppenheimer | Chris Kotowski | $85 | $61.55 | -29.5% | Jun 28, 2024 |
| RBC Capital | Gerard Cassidy | $66 | $59.67 | -45.3% | Jun 17, 2024 |
| Wells Fargo | Mike Mayo | $85 | $60.01 | -29.5% | Jun 13, 2024 |
| CFRA | Kenneth Leon | $71 | $63.02 | -41.1% | May 23, 2024 |
| UBS | Erika Najarian | $64 | $58.56 | -46.9% | Apr 15, 2024 |
| BMO Capital | James Fotheringham | $63 | $59.68 | -47.8% | Apr 15, 2024 |
| Goldman Sachs | Richard Ramsden | $69 | $59.12 | -42.8% | Apr 12, 2024 |
| Jefferies | Ken Usdin | $65 | $61.96 | -46.1% | Apr 8, 2024 |
| UBS | Erika Najarian | $66 | $62.29 | -45.3% | Apr 4, 2024 |
| Seaport Global | Jim Mitchell | $75 | $61.69 | -37.8% | Apr 4, 2024 |
| Evercore ISI | Glenn Schorr | $60 | $61.69 | -50.3% | Apr 4, 2024 |
| Goldman Sachs | Richard Ramsden | $68 | $57.09 | -43.6% | Mar 14, 2024 |
| Piper Sandler | Piper Sandler's | $63 | $53.9 | -47.8% | Feb 14, 2024 |
| Morgan Stanley | Betsy Graseck | $65 | $54.11 | -46.1% | Jan 30, 2024 |
| Wolfe Research | Steven Chubak | $58 | $53.48 | -51.9% | Jan 10, 2024 |
| Oppenheimer | Chris Kotowski | $88 | $46.29 | -27.0% | Jul 17, 2023 |
| Roth Capital | Susan Roth Katzke | $50 | $45.75 | -58.5% | Jul 17, 2023 |
| Piper Sandler | Scott Siefers | $48 | $48.71 | -60.2% | Jan 12, 2023 |
| Barclays | Jason Goldberg | $64 | $49.98 | -46.9% | Jul 17, 2022 |
| Morgan Stanley | Betsy Graseck | $57 | $46.87 | -52.7% | Jul 2, 2022 |
| Piper Sandler | Jeffery Harte | $62 | $46.87 | -48.6% | Jul 2, 2022 |
| RBC Capital | Gerard Cassidy | $60 | $46.87 | -50.3% | Jul 2, 2022 |
| Barclays | Jason Goldberg | $67 | $50.55 | -44.5% | Apr 11, 2022 |
| Piper Sandler | Jeffery Harte | $70 | $50.88 | -42.0% | Apr 8, 2022 |
| KBW | David Konrad | $64 | $57.62 | -46.9% | Mar 3, 2022 |
| Atlantic Equities | John Heagerty | $70 | $57.62 | -42.0% | Mar 3, 2022 |
| Bank of America Securities | Erika Najarian | $90 | $57.62 | -25.4% | Mar 3, 2022 |
| Deutsche Bank | Matt O'Connor | $66 | $59.56 | -45.3% | Mar 2, 2022 |
| Wells Fargo | Mike Mayo | $80 | $64.14 | -33.7% | Feb 20, 2022 |
| Oppenheimer | Chris Kotowski | $107 | $63.65 | -11.3% | Jan 27, 2022 |
| Evercore ISI | Glenn Schorr | $70 | $64.79 | -42.0% | Jan 18, 2022 |
| Societe Generale | Andrew T Lim | $72 | $64.4 | -40.3% | Jan 6, 2022 |
| Wolfe Research | Steven Chubak | $71 | $63.09 | -41.1% | Jan 4, 2022 |
| Odeon Capital Group LLC | Richard Bove | $69.25 | $59.77 | -42.6% | Dec 15, 2021 |
| Argus Research | Stephen Biggar | $87 | $70.35 | -27.9% | Apr 16, 2021 |
Track every rating change on C the moment it posts. Free to start.
Start freeCompany context
Snapshot as of publicationCitigroup, Inc. is a holding company, which engages in the provision of financial products and services. It operates through the following segments: Services, Markets, Banking, Wealth, U.S. Personal Banking (USPB), and All Other. The Services segment includes Treasury and Trade Solutions (TTS) which provides an integrated suite of tailored cash management, trade, and working capital solutions to multinational corporations, financial institutions and public sector organizations, and Securities Services, which offers cross-border support for clients, providing on-the-ground local market expertise, post-trade technologies, customized data solutions, and a wide range of securities services solutions that can be tailored to meet client needs.…
Historical context
All C earningsFinancial Services peers this season
Latest reports in the same sector
Latest beats and misses
Who reports nextBeat on EPS
- FCNCAFY2026 Q3 · October 23, 2026+19.9% EPS+8.2% move
- FCNCNFY2026 Q3 · October 23, 2026+19.9% EPS+0.2% move
- FCNCOFY2026 Q3 · October 23, 2026+19.9% EPS+1.0% move
- FCNCPFY2026 Q3 · October 23, 2026+19.9% EPS+1.0% move
- RDYFY2027 Q2 · October 23, 2026+24.0% EPS-0.2% move
- SLBFY2026 Q3 · October 23, 2026+3.7% EPS+7.1% move
Missed on EPS
- INFYFY2027 Q2 · October 23, 2026-4.8% EPS-6.6% move
- BBDFY2026 Q3 · October 22, 2026-7.7% EPS+3.0% move
- SNAFY2026 Q3 · October 22, 2026-5.9% EPS-3.4% move
- SPOTFY2026 Q3 · October 22, 2026-11.6% EPS+11.1% move
- VRSNFY2026 Q3 · October 22, 2026-2.0% EPS-0.9% move
- HBANMFY2026 Q3 · October 22, 2026-5.3% EPS+0.5% move
Get the C recap when the next report posts
One email per quarter with the scorecard, the market reaction and what changed on the call. No account needed.
Sources
- Earnings call transcript and parsed analysis · 2026-05-11T10:29:34.698584+00:00
- FN2 earnings calendar · 2024-10-17T05:10:49.140638+00:00
- Polygon adjusted daily market bars · 2026-10-25T08:10:42.053956+00:00
- Financial Modeling Prep analyst price-target consensus and quote snapshot · 2026-10-25T08:10:42.050745+00:00
Methodology
Reported and consensus figures come from FN2's earnings event records. Market reaction and volume are calculated from daily adjusted bars around the event; abnormal move subtracts the SPY move over the same window.
Analyst target low, average, and high values are derived at request time from each named analyst's latest persisted FMP target. The current-price marker comes from FN2's persisted market snapshot. They are sell-side estimates, not an FN2 valuation or recommendation.
Transcript intelligence is a structured synthesis of the current and prior earnings-call analyses. Missing values stay missing and are never estimated.
By FN2 Research · Updated · As of 2026-10-25. For educational purposes only; not investment advice.